Effect of increasing of insulin received pantoprazole in pregnant women with diabetes situation, blood glucose and glycosylated hemoglobin - a randomized clinical trial
Not Applicable
- Conditions
- Diabetes.Diabetes MellitusE10-14
- Registration Number
- IRCT201109274306N5
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Diabetic women of 20-35 years of age who are treated with insulin and who are in their 28th week of pregnancy will enter the study. Exclusion criteria: currently receiving proton pump inhibitors (omeprazole, Pantoprazole); IUGR detected by ultrasound; liver failure ( levels of liver enzymes more than three times the normal range), renal disease (Cr>1.5mg/dL); any diabetes complications; drinking alcohol or taking narcotics; hemoglobinopathies; reticulocytosis; anemia; blood transfusion needed during the study; uremia and any condition requiring hospitalization of the pregnant women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBA1C. Timepoint: Before and one month after pantoprazole tablet. Method of measurement: HB%.;C-peptide. Timepoint: Before and one month after pantoprazole tablet. Method of measurement: ng/ml.;FBS. Timepoint: Before and one month after pantoprazole tablet. Method of measurement: mg/dl.;Gastrin. Timepoint: Before and one month after pantoprazole tablet. Method of measurement: pmo/l.
- Secondary Outcome Measures
Name Time Method